Spironolactone Tablet, Film Coated
Product Images NDC 50090-6432

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 50090-6432). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure (Spironolactone 01)

Structure (Spironolactone 01)
FDA Label Image

Figure 1 (Spironolactone 02)

Figure 1 (Spironolactone 02)
FDA Label Image

Figure 2 (Spironolactone 03)

Figure 2 (Spironolactone 03)
This text seems to contain medical data and numeric values related to diabetes, subgroup, creatinine, potassium, and beta blocker. There is also a graph indicating the effectiveness of spironolactone compared to placebo. However, without further context, it is not possible to provide a more specific description or interpretation of the information.*
FDA Label Image

Label Image (Lbl500906432)

Label Image (Lbl500906432)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.